Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a potentially life‐threatening hypersensitive disorder. Cyclosporine has been indicated for adverse cutaneous drug eruptions. However, studies evaluating its clinical effectiveness… Click to show full abstract
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a potentially life‐threatening hypersensitive disorder. Cyclosporine has been indicated for adverse cutaneous drug eruptions. However, studies evaluating its clinical effectiveness in DRESS syndrome have been rare. This study aimed to evaluate the clinical efficacy of cyclosporine in DRESS syndrome compared to that of systemic corticosteroids.
               
Click one of the above tabs to view related content.